BDX — BCAL Diagnostics Share News
0.000.00%
- AU$27.65m
- AU$32.98m
- AU$2.55m
Australia Stock Exchange release from BCAL DIAGNOSTICS : letter to Shareholders AGM Notice
Australia Stock Exchange release from BCAL DIAGNOSTICS : Notice of Annual General Meeting/Proxy Form
Australia Stock Exchange release from BCAL DIAGNOSTICS : AGM Date and Closing Date for Director Nominations
Australia Stock Exchange release from BCAL DIAGNOSTICS : Appendix 4G and Corporate Governance Statement
Australia Stock Exchange release from BCAL DIAGNOSTICS : Annual Report to shareholders
Australia Stock Exchange release from BCAL : Change of Director's Interest Notice
Australia Stock Exchange release from BCAL : Change of Director's Interest Notice
Australia Stock Exchange release from BCAL : Australian Clinical Studies Launched
Australia Stock Exchange release from BCAL : PRE_NR Ends: 09:53:02
Australia Stock Exchange release from BCAL : Preliminary Final Report
Australia Stock Exchange release from BCAL : PRE_NR Ends: 11:04:44
Australia Stock Exchange release from BCAL : Market Update
Australia Stock Exchange release from BCAL : PRE_NR Ends: 10:36:46
Australia's biotech firm BCAL Diagnostics falls in market debut
Brief: BCAL Diagnostics To List On ASX After Raising A$10M In IPO